SEARCH

SEARCH BY CITATION

References

  • DICKINSON, K.E.J., TYMIAK, A.A., COHEN, R.B., LIU, E.C.-K., WEBB, M.L. & HEDBERG, A. (1991). Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase. Biochem. Biophys. Res. Commun., 176, 423429.
  • D'ORLÉANS-JUSTE, P., TÉLÉMAQUE, S. & CLAING, A. (1991). Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro. Br. J. Pharmacol., 104, 440444.
  • FUKURODA, T., NOGUCHI, K., TSUCHIDA, S., NISHIKIBE, M., IKEMOTO, F., OKADA, K. & YANO, M. (1990). Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun., 172, 390395.
  • GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1989a). Regional hemodynamic effects of endothelin-1 in conscious, unrestrained, Wistar rats. J. Cardiovasc. Pharmacol., 13 (Suppl. 5), S202S204.
  • GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1990a). Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious, Long Evans and Brattleboro rats. Br. J. Pharmacol., 99, 107112.
  • GARDINER, S.M., COMPTON, A.M. & BENNET, T. (1990b). Regional hemodynamic effects of endothelin-2 and sarafotoxin-S6b in conscious rats. Am. J. Physiol., 258, R912R917.
  • GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1990c). Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin. Br. J. Pharmacol., 100, 158162.
  • GARDINER, S.M., COMPTON, A.M., BENNETT, T., PALMER, R.M.J. & MONCADA, S. (1989b). NG-monomethyl-l-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur. J. Pharmacol., 171, 237240.
  • GARDINER, S.M., COMPTON, A.M., KEMP, P.A. & BENNETT, T. (1991). The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1–38] in conscious rats. Br. J. Pharmacol., 103, 20092015.
  • GARDINER, S.M., KEMP, P.A. & BENNETT, T. (1992a). Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1–38] in conscious rats. Br. J. Pharmacol., 106, 180186.
  • GARDINER, S.M., KEMP, P.A., BENNETT, T., PALMER, R.M.J. & MONCADA, S. (1992b). Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur. J. Pharmacol., 213, 449451.
  • GARDINER, S.M., KEMP, P.A., COMPTON, A.M. & BENNETT, T. (1992c). Coeliac haemodynamic effects of endothelin-1, endothelin-3, proendothelin-1 [1–38] and proendothelin-3 [1–41] in conscious rats. Br. J. Pharmacol., 106, 483488.
  • HAYWOOD, J.R., SHAFFER, R., FASTENOW, C., FINK, G.D. & BRODY, M.J. (1981). Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am. J. Physiol., 241, H273H278.
  • HIOKI, Y., OKADA, K., ITO, H., MATSUYAMA, K. & YANO, M. (1991). Endothelin converting enzyme of bovine carotid artery smooth muscles. Biochem. Biophys. Res. Commun., 174, 446451.
  • HISAKI, K., MATSUMURA, Y., IKEGAWA, R., NISHIGUCHI, S., HAYASHI, K., TAKAOKA, M. & MORIMOTO, S. (1991). Evidence for phosphoramidon-sensitive conversion of big endothelin-1 to endothelin-1 in isolated rat mesenteric artery. Biochem. Biophys. Res. Commun., 177, 11271131.
  • IKEGAWA, R., MATSUMURA, Y., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1991). Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells. FEBS Lett., 293, 4548.
  • DE GOUVILLE, LE MONNIER A.-C. & CAVERO, I. (1991). Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin. Br. J. Pharmacol., 104, 7784.
  • MATSUMURA, Y., HISAKI, K., TAKAOKA, M. & MORIMOTO, S. (1990a). Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur. J. Pharmacol., 185, 103106.
  • MATSUMURA, Y., IKEGAWA, R., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1990b). Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett., 272, 166170.
  • MATSUMURA, Y., IKEGAWA, R., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1991a). N-ethylmaleimide differentiates endothelin converting activity by two types of metalloproteinases derived from vascular endothelial cells. Biochem. Biophys. Res. Commun., 178, 531538.
  • MATSUMURA, Y., IKEGAWA, R., TSUKAHARA, Y., TAKAOKA, M. & MORIMOTO, S. (1991b). Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 178, 899905.
  • McMAHON, E.G., PALOMO, M.A., MOORE, W.M., McDONALD, J.F. & STERN, M.K. (1991). Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1–39) in vivo and conversion of big endothelin-1-(1–39) to endothelin-1-(1–21) in vitro. Proc. Natl. Acad. Sci. U.S.A., 88, 703707.
  • MODIN, A., PERNOW, J. & LUNDBERG, J.M. (1991). Phosphoramidon inhibits the vasoconstrictor effects evoked by big endothelin-1 but not the elevation of plasma endothelin-1 in vivo. Life Sci., 49, 16191625.
  • MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Res., 43, 109142.
  • OKADA, K., MIYAZAKI, Y., TAKADA, J., MATSUYAMA, K., YAMAKI, T. & YANO, M. (1990). Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun., 171, 11921197.
  • OKADA, K., TAKADA, J., ARAI, Y., MATSUYAMA, K. & YANO, M. (1991). Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Biochem. Biophys. Res. Commun., 180, 10191023.
  • POLLOCK, D.M. & OPGENORTH, T.J. (1991). Evidence for metalloprotease involvement in the in vivo effects of big endothelin-1. Am. J. Physiol., 261, R257R263.
  • SOKOLOVSKY, M., GALRON, R., KLOOG, Y., BDOLAH, A., INDIG, F.E., BLUMBERG, S. & FLEMINGER, G. (1990). Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: Possible physiological significance. Proc. Natl. Acad. Sci. U.S.A., 87, 47024706.
  • TAKADA, J., HATA, M., OKADA, K., MATSUYAMA, K. & YANO, M. (1992). Biochemical properties of endothelin converting enzyme in renal epithelial cell lines. Biochem. Biophys. Res. Commun., 182, 13831388.
  • TAKADA, J., OKADA, K., IKENAGA, T., MATSUYAMA, K. & YANO, M. (1991). Phosphoramidon-sensitive endothelin-converting enzyme in the cytosol of cultured bovine endothelial cells. Biochem. Biophys. Res. Commun., 176, 860865.
  • TÉLÉMAQUE, S. & D'ORLÉANS-JUSTE, P. (1991). Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens. Naunyn-Schmiedebergs Arch. Pharmacol., 344, 505507.
  • THEODORSSON-NORHEIM, E. (1987). Freidman and Quade tests: BASIC computer program to perform non-parametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput. Biol. Med., 17, 8599.
  • VIJAYARAGHAVAN, J., SCICLI, A.G., CARRETERO, O.A., SLAUGHTER, C., MOOMAW, C. & HERSH, L.B. (1990). The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem., 265, 1415014155.
  • WATANABE, Y., NARUSE, M., MONZEN, C., NARUSE, K., OHSUMI, K., HORIUCHI, J., YOSHIHARA, I., KATO, Y., NAKAMURA, N., KATO, M., SUGINO, N. & DEMURA, H. (1991). Is big endothelin converted to endothelin-1 in circulating blood J. Cardiovasc. Pharmacol., 17 (Suppl. 7), S503S505.
  • YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411415.